Opinion of Brazilian Gynecologists on Hormone Therapy for Menopause and Prescriptive Habits

Opinion of Brazilian Gynecologists on Hormone Therapy for Menopause and Prescriptive

To evaluate Brazilian gynecologists, through structured online questionnaires, with questions directed to their opinions and prescriptive habits about menopause hormone therapy. Research participants will complete the questionnaires in digital format online.

Study Overview

• Status: Completed
• Conditions: Menopause; Hormone Replacement Therapy; Opinions
• Intervention / Treatment: Other: Applying a questionnaire

Detailed Description

There are few Brazilian population studies on the opinion of Brazilian gynecologists about the hormonal therapy of menopause in climacteric women, their prescriptive habits and their views on the availability of treatments offered, demanding better evaluation and justifying efforts to analyze the perception of professionals in this area in our country.

Methods: To assess gynecologists across the country, through structured online questionnaires, with questions aimed at knowing their opinions and prescriptive habits about menopause hormone therapy. Research participants will complete the questionnaires in digital format online. Doctors will be invited to participate by e-mail messages and by social media.

• Study Type: Observational
• Enrollment (Actual): 1339

Contacts and Locations

Study Locations

• Brazil
  • SP
    • São Bernardo do Campo, SP, Brazil, 09760-280
      • Centro de Atenção Integral à Saúde da Mulher

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult; Older Adult
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Active Brazilian licensed gynecologist doctors who see patients

Description

Inclusion Criteria:

• Brazilian licensed gynecologist doctors

Exclusion Criteria:

• Retired doctors
• Health professionals other than medicine doctor
• Medical specialties other than Gynecology
• Medical employees of the pharmaceutical industry

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Gynecologists; Brazilian gynecologists who agreed to participate and answered the questionnaire	Other: Applying a questionnaire; The participants have to answer a questionnaire addressing their opinion on menopausal hormone replacement therapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Prescription preference	Answer to the questionnaire addressing gynecologists' prescription habit for menopausal women	At Day 1

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Knowledge of window of opportunity for hormone replacement therapy	This is to see which proportion of gynecologists know the principle of window of opportunity for menopausal hormone replacement therapy	At Day 1
Knowledge of indications and contraindications of hormone replacement therapy	This is to see which proportion of gynecologists know the indications and contraindicationsv of menopausal hormone replacement therapy	At Day 1

Collaborators and Investigators

• Sponsor: Faculdade de Medicina do ABC

Publications and helpful links

General Publications

• Taylor HS, Kagan R, Altomare CJ, Cort S, Bushmakin AG, Abraham L. Knowledge of clinical trials regarding hormone therapy and likelihood of prescribing hormone therapy. Menopause. 2017 Jan;24(1):27-34. doi: 10.1097/GME.0000000000000711.
• Buhling KJ, von Studnitz FS, Jantke A, Eulenburg C, Mueck AO. Use of hormone therapy by female gynecologists and female partners of male gynecologists in Germany 8 years after the Women's Health Initiative study: results of a survey. Menopause. 2012 Oct;19(10):1088-91. doi: 10.1097/gme.0b013e318250bfda.
• Yeganeh L, Boyle J, Teede H, Vincent A. Knowledge and attitudes of health professionals regarding menopausal hormone therapies. Climacteric. 2017 Aug;20(4):348-355. doi: 10.1080/13697137.2017.1304906. Epub 2017 Apr 5.

Study record dates

Study Major Dates

• Study Start (Actual): April 28, 2021
• Primary Completion (Actual): September 4, 2021
• Study Completion (Actual): September 4, 2021

Study Registration Dates

• First Submitted: September 17, 2021
• First Submitted That Met QC Criteria: September 28, 2021
• First Posted (Actual): October 11, 2021

Study Record Updates

• Last Update Posted (Actual): October 11, 2021
• Last Update Submitted That Met QC Criteria: September 28, 2021
• Last Verified: September 1, 2021

More Information

Terms related to this study

• Other Study ID Numbers: 40147120.8.0000.0082

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO
• IPD Plan Description: This is not an interventional study, so, the researches understand that there is no reason to share individual participant data.

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No